“…Furthermore, the heart-surrounding configuration of such devices is likely to constrain ventricular filling and impair early diastolic relaxation. To overcome such shortcomings, we used a novel design consisting of independent nonsurround RV-and LV-apposed pumping chambers (HeartPatch-DCC device; Heart Assist Technologies, St Leonards, NSW, Australia; Figure 1), which has been shown to have potent ability to increase cardiac output 15 and restore myocardial efficiency during pharmacologically induced heart failure. 16 This device was implanted in sheep hearts with septal pathologic features, as previously described, 17 to compare the RV in-series, load-independent, and geometric responses to that of previously studied inline mechanical LVAD unloading.…”